Results 191 to 200 of about 198,039 (308)

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng, Charlotte McKay, Victoria Bray, Po Yee Yip, Annette Tognela, Peey Sei Kok   +5 more
wiley   +1 more source

Evaluating the Reproductive Impact of Pembrolizumab in Mice: Ovarian Function and Hormonal Changes. [PDF]

In Vivo
Sütcüoğlu BM, Sütcüoğlu O, Öğüt B, Akdoğan O, Kodaz ÇE, Yilmaz C, Erdem Ö, Anadol E, Özdemir N.   +8 more
europepmc   +1 more source

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors. [PDF]

, 2020
Cohen, Philip R, Kurzrock, Razelle
core   +1 more source

Case: A Case of pembrolizumab induced myocarditis and complete heart block

Janak Adhikari, Priyadarshani Sharma, Eddy Karnabi, Juan H. Merchan, Hasnain Arshad   +4 more
openalex   +2 more sources

606 Phase I trial of in situ vaccination with autologous CCL21 gene-modified dendritic cells (CCL21-DC) combined with pembrolizumab for metastatic NSCLC [PDF]

Aaron Lisberg, Bin Liu, Michael S. Oh, Camelia Dumitras, Olga Tsvetkova, Ramin Salehi‐Rad, Linh M. Tran, Kostyantyn Krysan, Raymond J. Lim, Maryam Shabihkhani, Tahmineh Romero, Zhe Jing, Fereidoun Abtin, Robert D. Suh, Scott Genshaft, Scott Oh, Gregory A. Fishbein, Cindy S.W. Tong, Alexander Yaw Fui Chung, Sílvia Hernández, James Chauv, Jackson P Lind-Lebuffe, Lauren Winter, Christine Kivork, Kimberly M. Kelly, Daniel Greenwald, Kanwarpal Kahlon, Sidharth Anand, Shahryar Ashouri, Jonathan W. Goldman, Jay M. Lee, David Elashoff, Edward B. Garon, Steven M. Dubinett   +33 more
openalex   +1 more source

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown, Graham Meredith, Bo Gao, Pei Ding, Harriet Gee, Inês Pires da Silva, Adnan Nagrial, Eric Hau   +7 more
wiley   +1 more source

Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report. [PDF]

Cureus
Kafka W, Frandah W, Diks J.
europepmc   +1 more source

548 A Phase 1/2 study of a first-in-class non-cellular antibody-drug conjugate, micvotabart pelidotin (micvo), in combination with pembrolizumab in advanced head & neck squamous cell carcinoma (HNSCC) [PDF]

Glenn J. Hanna, Faye M. Johnson, Dan P. Zandberg, Guilherme Rabinowits, Noura J. Choudhury, Peter Vu, Lova Sun, Gregory M. Coté, Lori J. Wirth, Alexander I. Spira, Sant P. Chawla, Marcos Ramirez-Marquez, Dipali Unadkat, Mason L. Mann, Xiaoping Qing, Hongwei Wang, Sarina A. Piha‐Paul   +16 more
openalex   +1 more source

Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski, Mahima Raju, Tracy Fitzsimmons, Ishraq Murshed, Timothy J. Price, Michael Penniment, Sudarsha Selva‐Nayagam, Tarik Sammour   +7 more
wiley   +1 more source

Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025. [PDF]

CA Cancer J Clin
Jang A, Zakharia Y, Barata PC.
europepmc   +1 more source